According to the latest report by IMARC Group, titled “Neurorehabilitation Devices Market: Global Industry, Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global neurorehabilitation devices market reached a value of US$ 1.7 Billion in 2022. Neurorehabilitation devices refer to the equipment used to examine the brain or central nervous system. They consist of non-invasive brain stimulators, neurorobotic systems, brain-computer interfaces, and wearable devices that send specific electric signals to fibers of the spinal cord to recover limb movement. Neurorehabilitation devices are intended to improve neurological functions, diagnose and treat diseases pertaining to the nervous system, and alleviate symptoms, thus ensuring the well-being of an individual. As a result, they are widely used in optimal recovery from multiple sclerosis and neurological disorders, such as Parkinson’s disease and cardiovascular stroke.
Global Neurorehabilitation Devices Market Trends:
The increasing incidences of neurological disorders, such as stroke, meningitis, tetanus, encephalitis, epilepsy, multiple sclerosis, and migraine, are key factors driving the market growth. Additionally, the rising geriatric population across the globe that is more susceptible to such ailments is favoring the market growth. Neurorehabilitation devices are widely used in upper or lower extremities exercises to promote neuro-motor recovery. Apart from this, the integration of virtual reality (VR), robotics, and artificial intelligence (AI), with neurorehabilitation devices to track limb movement, provide personalized training, and promote recovery are providing an impetus to the market growth. In line with this, the launch of voice-recognition algorithms to enhance the functionality and flexibility of the devices and the utilization of the Internet of Things (IoT) with rehabilitation robotics to assist healthcare professionals in delivering assessment and treatment to patients over the internet are positively influencing the market growth. Other factors, including the rising healthcare expenditure capacities of the masses, the emergence of wearable technology, and extensive research and development (R&D) activities, are anticipated to drive the market further. On account of the aforementioned factors, the market value is expected to reach US$ 3.1 Billion by 2028, exhibiting a CAGR of 10.5% during 2023-2028.
- Based on the product type, the market has been classified into neurorobotic devices, wearable devices, non-invasive stimulators, and brain-computer interface.
- On the basis of the application, the market has been divided into stroke, multiple sclerosis, Parkinson's disease, cerebral palsy, and others.
- Based on the end user, the market has been categorized into hospitals and clinics, cognitive care centers, and others.
- On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and Others) Latin America (Brazil, Mexico and Others), and Middle East and Africa.
- The competitive landscape of the industry has also been examined, with some of the key players being Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH.
|Base Year of the Analysis
||Product Type, Application, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800